PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)
pro-Spinoza
Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium
1 other identifier
interventional
24
1 country
4
Brief Summary
It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2014
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 10, 2014
CompletedFirst Posted
Study publicly available on registry
October 16, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedNovember 29, 2017
November 1, 2017
2.2 years
October 10, 2014
November 27, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)
The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital
6 months
Secondary Outcomes (4)
cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)
6 months
consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)
6 months
consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)
6 months
consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)
6 months
Study Arms (5)
Research cluster 1: Antwerp
OTHERThe first Dutch-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2014.
Research cluster 2: Mons
OTHERThe first French-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from November 2014.
Research cluster 3: Brussels
OTHERThe only bilingual Dutch/French-speaking research cluster in a stepped wedge cluster design. Family doctors are implementing the Care Pathway for Primary Palliative Care and will recruit eligible patients from December 2014.
Research cluster 4: Limburg
OTHERThe second Dutch-speaking research cluster in a stepped wedge cluster design. Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from April 2015.
Research cluster 5: ?
OTHERA second French-speaking research cluster in a stepped wedge cluster design. Family doctors will implement the Care Pathway for Primary Palliative Care and will recruit eligible patients from October 2015.
Interventions
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.
Eligibility Criteria
You may qualify if:
- identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.
You may not qualify if:
- not having signed the informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bert Leysenlead
- Intermutualistic Agencycollaborator
- National Institute for Health and Disability Insurance, Belgiumcollaborator
Study Sites (4)
Reliance
Mons, Hainaut, Belgium
Netwerk Palliatieve Zorg Limburg
Hasselt, Limburg, Belgium
Palliatieve Hulpverlening Antwerpen
Antwerp, Belgium
Palliabru
Brussels-Capital Region, Belgium
Related Publications (2)
Leysen B, Van den Eynden B, Janssens A, Wens J. Recruiting general practitioners for palliative care research in primary care: real-life barriers explained. BMC Fam Pract. 2019 Mar 5;20(1):40. doi: 10.1186/s12875-019-0930-y.
PMID: 30836994DERIVEDLeysen B, Van den Eynden B, Gielen B, Bastiaens H, Wens J. Implementation of a Care Pathway for Primary Palliative Care in 5 research clusters in Belgium: quasi-experimental study protocol and innovations in data collection (pro-SPINOZA). BMC Palliat Care. 2015 Sep 28;14:46. doi: 10.1186/s12904-015-0043-x.
PMID: 26416574DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bart Van den Eynden, MD, PhD
Universiteit Antwerpen
- PRINCIPAL INVESTIGATOR
Johan Wens, MD, PhD
Universiteit Antwerpen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, PhD candidate
Study Record Dates
First Submitted
October 10, 2014
First Posted
October 16, 2014
Study Start
October 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
November 29, 2017
Record last verified: 2017-11